CANGENE TO BE ACQUIRED BY EMERGENT BIOSOLUTIONS FOR US$222 MILLION

By

CANGENE CORP SAYS CREDIT SUISSE SECURITIES (CANADA), INC. IS ACTING AS FINANCIAL ADVISOR TO CANGENE.

CANGENE CORP SAYS CANGENE SHAREHOLDERS TO RECEIVE US$3.24PER SHARE (C$3.44PER SHARE) IN CASH.

EMERGENT-SECURED COMMITTED DEBT FINANCING TOTALING $225 MLN, WHICH COMBINED WITH EXISTING CASH RESERVES TO BE USED TO FINANCE DEAL,REPAY INDEBTEDNESS.

EMERGENT BIOSOLUTIONS INC SAYS ALSO ANTICIPATES THERE WILL BE APPROXIMATELY $35 MILLION OF CASH FROM CANGENE AT CLOSING.

EMERGENT BIOSOLUTIONS INC - SEES REVENUE CONTRIBUTION FROM DEAL OF $90 TO $100 MILLION FOR THE PARTIAL YEAR PERIOD OF 2014.

EMERGENT BIOSOLUTIONS -REAFFIRMING ITS FULL YEAR 2013 GAAP GUIDANCE FOR TOTAL REVENUES OF $300 TO $310 MILLION AND NET INCOME OF $25 TO $30 MILLION.

© 2017 VCWHO.com All rights reserved. Do not reproduce without permission.

Join the Conversation

Real Time Analytics